Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis oil versus NSAID for acute migraine attack
MOH_2018-07-11_002505Phase 2Not yet recruiting
- Sponsor
- TO Pharma
- Start
- Oct 2016
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabis oil in migraine (2 arms), sponsored by TO Pharma. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
cannabis oil
03
Conditions
migraine
Beyond the preview
Go deeper on MOH_2018-07-11_002505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-07-11_002505.